Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories gains on launching Bivalirudin for Injection in US market
>>
Dr. Reddys Laboratories informs about press release
>>
Dr. Reddy’s Laboratories launches Bivalirudin for Injection in US market
>>
Dr. Reddy's Laboratories informs about allotment of equity shares
>>
Dr. Reddy’s trades with traction on the bourses
>>
Dr. Reddy’s advances on successfully completing USFDA audit for Srikakulum Plant
>>
Dr. Reddy’s successfully completes USFDA audit for Srikakulum Plant
>>
Dr. Reddy’s partners DST, UoH to develop anti-psoriatic drugs
>>
Dr Reddy’s rises on receiving approval for Doxorubicin Hydrochloride Liposome Injection launch
>>
Dr Reddy’s receives approval for Doxorubicin Hydrochloride Liposome Injection launch
<<
<
89
90
91
...145
>
>>